RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Murali Yallapu to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Murali Yallapu has written about Clinical Trials, Phase II as Topic.
Murali Yallapu
Connection Strength
0.167
Clinical Trials, Phase II as Topic
  1. Hatami E, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188381.
    View in: PubMed
    Score: 0.167
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support